MICU intern's survival guide vasopressors

Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.D. [2]

WikiDoc Resources for MICU intern's survival guide vasopressors

Articles

Most recent articles on MICU intern's survival guide vasopressors

Most cited articles on MICU intern's survival guide vasopressors

Review articles on MICU intern's survival guide vasopressors

Articles on MICU intern's survival guide vasopressors in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on MICU intern's survival guide vasopressors

Images of MICU intern's survival guide vasopressors

Photos of MICU intern's survival guide vasopressors

Podcasts & MP3s on MICU intern's survival guide vasopressors

Videos on MICU intern's survival guide vasopressors

Evidence Based Medicine

Cochrane Collaboration on MICU intern's survival guide vasopressors

Bandolier on MICU intern's survival guide vasopressors

TRIP on MICU intern's survival guide vasopressors

Clinical Trials

Ongoing Trials on MICU intern's survival guide vasopressors at Clinical Trials.gov

Trial results on MICU intern's survival guide vasopressors

Clinical Trials on MICU intern's survival guide vasopressors at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on MICU intern's survival guide vasopressors

NICE Guidance on MICU intern's survival guide vasopressors

NHS PRODIGY Guidance

FDA on MICU intern's survival guide vasopressors

CDC on MICU intern's survival guide vasopressors

Books

Books on MICU intern's survival guide vasopressors

News

MICU intern's survival guide vasopressors in the news

Be alerted to news on MICU intern's survival guide vasopressors

News trends on MICU intern's survival guide vasopressors

Commentary

Blogs on MICU intern's survival guide vasopressors

Definitions

Definitions of MICU intern's survival guide vasopressors

Patient Resources / Community

Patient resources on MICU intern's survival guide vasopressors

Discussion groups on MICU intern's survival guide vasopressors

Patient Handouts on MICU intern's survival guide vasopressors

Directions to Hospitals Treating MICU intern's survival guide vasopressors

Risk calculators and risk factors for MICU intern's survival guide vasopressors

Healthcare Provider Resources

Symptoms of MICU intern's survival guide vasopressors

Causes & Risk Factors for MICU intern's survival guide vasopressors

Diagnostic studies for MICU intern's survival guide vasopressors

Treatment of MICU intern's survival guide vasopressors

Continuing Medical Education (CME)

CME Programs on MICU intern's survival guide vasopressors

International

MICU intern's survival guide vasopressors en Espanol

MICU intern's survival guide vasopressors en Francais

Business

MICU intern's survival guide vasopressors in the Marketplace

Patents on MICU intern's survival guide vasopressors

Experimental / Informatics

List of terms related to MICU intern's survival guide vasopressors

Overview

Shock is a common condition that interns have to encounter in the MICU. Some important ideas to keep in mind while managing shock are: determine the type of shock as the treatment is different for different shocks, norepinephrine can be used as a first line vasopressor in any shock and fluid resuscitation is an important first line management in all type of shocks except cardiogenic shock.

Norepinephrine

Mechanism of action

Acts on both alpha1 (vasoconstriction of blood vessels) and beta1 receptors (increases cardiac output).

Indications

Doses

  • 1-30 mcg/min.

Dopamine

Mechanism of action

  • Acts on alpha1 (vasoconstriction of blood vessels), beta1 (increases cardiac output) and dopamine receptors (scattered throughout the body).
  • Its action is dose dependent. At low doses it predominantly acts on cardiac receptors (1-10 mcg/min) with less vasoconstriction activities. At higher doses it has both vasoconstriction and cardiac activities.

Indications

Side-effects

  • Arrhythmogenic. Avoid in patients prone to arrhythmias.
  • Doses
  • 1-20 mcg/min.

Vasopressin

Mechanism of action

  • Acts by stimulating V1 (vasopressin) receptors in vascular and GI smooth muscles causing contraction. It also has anti-diuretics effect.

Indications

Side-effects

Doses

  • .03units/min (only vasopressor which is not titrated).

Phenylephrine

Mechanism of action

  • Acts only on alpha1 receptors (vasoconstriction). No action on cardiac receptors and is cardiac neutral.

Indications

Side-effects

Doses

  • 20-300 mcg/min

Dobutamine

Mechanism of action

  • Acts on Beta1 (increases cardiac output) and Beta2 receptor (vasodilatation). Thus, it increases cardiac output but increases the risks for hypotension too.

Indications

Side-effects

  • Tachyarrhythmias (B1 effect)
  • Hypotension (B2 effect)
  • In cases of hypotension with dobutamine add another vasopressor with alpha effects (norepinephrine or dopamine) with dobutamine.

Doses

  • 2.5 to 20mcg/kg/min (usually titrated by doctors and not ICU nurses)

References

Template:WH Template:WS